Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
VNDA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
30.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
132.30%
VNDA Stock Analysis
VNDA
PE Ratio:
VNDA
PEG Ratio:
Not Available
VNDA
Forward EPS Growth (12 month):
0.00%
VNDA
PS Ratio:
1.7
VNDA
PSG Ratio:
VNDA
Forward Revenue Growth (12 month):
35.50%
VNDA Articles
No data was found